Business Context and Reporting Period
Company: AMBEV S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Second Quarter (2Q) ended June 30, 2021, and Year-to-Date (HY21).
Context: Ambev reported record consolidated volumes for a second quarter, driven by commercial strategy, innovation, and operational excellence. The company is navigating economic reopening and vaccination progress while managing persistent COVID-19 headwinds and commodity cost pressures.
Key Financial Metrics (2Q21 vs. 2Q20)
| Metric | 2Q20 (R$ million) | 2Q21 (R$ million) | Change (Organic %) |
|---|---|---|---|
| Volume ('000 hl) | 33,465.6 | 39,807.6 | +19.0% |
| Net Revenue | 11,615.3 | 15,711.1 | +36.2% |
| Gross Profit | 5,813.5 | 7,745.9 | +34.7% |
| Gross Margin | 50.0% | 49.3% | -70 bps |
| Normalized EBITDA | 3,348.3 | 5,289.2 | +24.0% |
| Normalized EBITDA Margin | 28.8% | 33.7% | +490 bps |
| Normalized Profit | 1,372.6 | 2,962.7 | +115.9% |
| Cash Flow from Operating Activities | 1,838.8 | 1,873.5 | +1.9% |
| Net Debt/(Cash) | (13,998.1) | (11,430.3) | N/A |
Note: All figures in Brazilian Reais (R$). Net Debt is negative, indicating a net cash position.
Material Changes vs. Prior Period
- Volume Growth: Consolidated volumes reached an all-time high for a second quarter, up 19.0% organically. Growth was broad-based: Brazil (+15.7%), Central America & Caribbean (CAC) (+62.7%), Latin America South (LAS) (+26.8%), while Canada declined slightly (-0.9%) due to ongoing restrictions.
- Revenue Drivers: Net revenue grew 36.2% organically, driven by volume and a 14.5% increase in Net Revenue per hectoliter (NR/hl) due to premiumization and revenue management.
- Cost Pressures: Cost of Goods Sold (COGS) per hectoliter increased 15.7% due to foreign exchange (FX) and commodity impacts. SG&A expenses grew 35.6% due to variable compensation, distribution costs, and marketing investments.
- Tax Credits: Results were positively impacted by R$1,604.0 million in tax credits related to a 2017 Brazilian Supreme Court decision regarding ICMS, PIS, and COFINS taxes. R$1,219.2 million was recorded in Other Operating Income.
- Argentina Hyperinflation: Application of IAS 29 (Hyperinflation Accounting) for Argentine operations resulted in a negative impact on Normalized Profit of R$304.0 million for 2Q21.
Guidance, Outlook, and Risks
- Management Outlook: Management expects top-line recovery to continue ahead of bottom-line recovery for the full year due to persistent cost pressures (commodities and FX) and SG&A investments.
- Strategic Initiatives: Continued expansion of digital platforms (BEES, Donus, Zé Delivery) and premiumization strategies are key growth drivers. ESG targets include a 25% reduction in carbon emissions by 2025 and 100% renewable electricity.
- Risks and Contingencies:
- Commodity & FX Volatility: Ongoing pressure on COGS from global commodity prices and currency fluctuations.
- COVID-19: Continued restrictions in certain markets (e.g., Canada) impacting on-premise consumption.
- Hyperinflation: Significant accounting adjustments required for operations in Argentina.
- Exceptional Items: R$85.7 million in exceptional items (COVID-19 costs, restructuring) impacted 2Q21 results.
Investor Verification Checklist
- Tax Credit Sustainability: Verify the long-term sustainability of the R$1.6 billion tax credit benefit and its exclusion from organic performance metrics.
- Argentina Exposure: Assess the magnitude of the IAS 29 hyperinflation adjustments on future earnings and cash flows.
- Margin Compression: Monitor the trajectory of COGS and SG&A growth relative to revenue to determine when bottom-line recovery will match top-line growth.
- Canada Performance: Track volume recovery in Canada as on-premise restrictions ease, given the current slight decline.
- Net Cash Position: Confirm the utilization of the R$11.4 billion net cash position for debt reduction, dividends, or strategic investments.